Bright Minds Biosciences Inc.
DRUG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001827401
No open-market purchases or sales by Bright Minds Biosciences Inc. insiders were filed in the last 90 days; 99 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Bright Minds Biosciences Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 6 | 31 | +25 |
| Shares | 191.5K | 4.90M | +4.71M (+2,456.6%) |
| Value | $229.8K | $176.4M | +$176.2M (+76,662.1%) |
New holders (26)
Institutions that held Bright Minds Biosciences Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (1)
Institutions that held Bright Minds Biosciences Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Aspire Private Capital, LLC | 100 | $117 |